In Depth 7 Mar 2025
Catalonia: A biotech hub going from strength to strength, with Barcelona at its core
Take a deeper look at Catalonia’s biotech sector and overall life sciences hub, including the key drivers behind its success.
Research
- Latest Posts
R&D trends: Biotech assets & discovery platforms
Inpart’s latest report provides access to the most promising biotech assets and discovery platforms, shedding light on the latest trends in biotech R&D.
Best in Biotech 25 Feb 2025
Seven biotech spinouts to watch out for in 2025
Here are seven biotech spinouts to keep an eye out for this year that specialize in a number of therapeutic areas.
Best in Biotech 21 Jan 2025
14 biotech podcasts to tune into in 2025
Here is a list of 14 biotech podcasts to keep you up to date with the latest advances in the biotechnology industry.
Best in Biotech 17 Oct 2024
Top six European biotech entrepreneurs to know in 2024 (according to VCs)
We reached out to VCs to nominate prominent European entrepreneurs in the biotech industry who are committed to bringing potentially life-changing treatments to market.
The future of epilepsy treatment: pioneering advances and patient-centric care
Epilepsy, one of the most widespread neurological diseases in the world, characterized by recurrent seizures, affects approximately 50 million people globally. In Europe, up to six million people are estimated to be living with the disease. Whilst treatment options have come a long way over the last few decades, clinical practice still shows significant unmet […]
ADVERTISEMENT
ADVERTISEMENT
In Depth 9 Oct 2024
Promising cure for COPD: Is a breakthrough treatment within reach?
Find out whether a promising cure for COPD is within reach, after recent advancements in treatments and research around the disease.
News and Trends 12 Sep 2024
Biotech R&D crunch: The impact of the Inflation Reduction Act and economic challenges
Delve into the consequences of the Inflation Reduction Act and the broader economic conditions on biotech R&D.
News and Trends 11 Sep 2024
Can Europe revive its biopharma innovation leadership?
Find out if the biotech runner-up, Europe, can step up to boost research and revive its innovation leadership.
In Depth 8 Jul 2024
Bridge RNA: A new gene editing technique that could overcome the limitations of CRISPR
Find out how the recent discovery of a molecular oddity found in bacteria has led to a new gene editing technique.
In Depth 17 Jun 2024
Moving with the times: biopharma royalty deals on the rise
A spate of royalty deals are changing the way certain biotechs press ahead. This trend seems to be an alternative to traditional biopharma fundraising.
In Depth 30 May 2024
Covalent biologics: a new class of drugs on the horizon
The field of covalent biologics has made headway recently, as the only biotech in the space has bagged $100 million to move its pipeline to the clinic.
ADVERTISEMENT
